, Tracking Stock Market Picks
Enter Symbol:

up 49.16 %

MEDASSETS INC. (MDAS) rated Buy with price target $17 by ThinkEquity

Posted on: Thursday,  Mar 12, 2009  8:25 AM ET by ThinkEquity

ThinkEquity rated Buy MEDASSETS INC. (NASDAQ: MDAS) on 03/12/2009, when the stock price was $13.85. Since
then, MEDASSETS INC. has gained 49.17% as of 12/29/2015's recent price of $20.66.
If you would have followed this ThinkEquity's recommendation on MDAS, you would have gained 49.16% of your investment in 2483 days.

MedAssets, Inc. provides technology-enabled products and services, which together deliver solutions designed to improve operating margin and cash flow for hospitals and health systems. These solutions are offered primarily through Company-hosted software, or software as a service (SaaS), supported by enterprise-wide sales, account management, implementation services and consulting. The Company delivers its solutions through two business segments: Revenue Cycle Management, which provides a suite of products and services that span what has traditionally been viewed as the hospital revenue cycle, and Spend Management, which helps customers manage their non-labor expense categories through a combination of group purchasing, performance improvement consulting, including implantable physician preference items (PPI), cost and utilization management and service line consulting, and business intelligence tools. On June 2, 2008, the Company acquired Accuro Healthcare Solutions, Inc.

Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/12/2009 8:25 AM Buy
13.85 17.00
as of 12/31/2009
1 Week down  -7.18 %
1 Month down  -14.82 %
3 Months down  -11.91 %
1 YTD up  43.53 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy